HIV molecular immunology database

 

Search Antibody Database

Found 3 matching records:

Displaying record number 1243

Download this epitope record as JSON.

MAb ID polyclonal
HXB2 Location Vpr Vpr Epitope Map
Author Location Vpr( 89.6)
Epitope
Subtype B
Ab Type  
Neutralizing  
Species (Isotype) human(IgG)
Patient  
Immunogen HIV-1 infection
Country France
Keywords rate of progression

Notes

Showing 1 of 1 note.

References

Showing 1 of 1 reference.

Richardson2003 Max W Richardson, Jyotika Mirchandani, Joseph Duong, Sammy Grimaldo, Virginia Kocieda, Houria Hendel, Kamel Khalili, Jean-François Zagury, and Jay Rappaport. Antibodies to Tat and Vpr in the GRIV Cohort: Differential Association with Maintenance of Long-Term Non-Progression Status in HIV-1 Infection. Biomed. Pharmacother., 57(1):4-14, Jan 2003. PubMed ID: 12642031. Show all entries for this paper.


Displaying record number 1242

Download this epitope record as JSON.

MAb ID polyclonal
HXB2 Location Tat Tat Epitope Map
Author Location Tat( IIIB, 89.6, CMU08)
Epitope
Subtype B, CRF01_AE
Ab Type C-term, N-term, Tat basic region
Neutralizing  
Species (Isotype) human(IgG)
Patient  
Immunogen HIV-1 infection, vaccine
Country France
Keywords antibody binding site, rate of progression, subtype comparisons, vaccine-induced immune responses

Vaccine Details

Vaccine type protein
Vaccine strain B clade
Vaccine component Tat

Notes

Showing 1 of 1 note.

References

Showing 1 of 1 reference.

Richardson2003 Max W Richardson, Jyotika Mirchandani, Joseph Duong, Sammy Grimaldo, Virginia Kocieda, Houria Hendel, Kamel Khalili, Jean-François Zagury, and Jay Rappaport. Antibodies to Tat and Vpr in the GRIV Cohort: Differential Association with Maintenance of Long-Term Non-Progression Status in HIV-1 Infection. Biomed. Pharmacother., 57(1):4-14, Jan 2003. PubMed ID: 12642031. Show all entries for this paper.


Displaying record number 1245

Download this epitope record as JSON.

MAb ID polyclonal
HXB2 Location Tat Tat Epitope Map
Author Location Tat( IIIB, 89.6, CMU08)
Epitope
Subtype B, CRF01_AE
Ab Type C-term, N-term, Tat basic region
Neutralizing  
Species (Isotype) human(IgG)
Patient  
Immunogen HIV-1 infection, vaccine
Country France
Keywords antibody binding site, rate of progression, subtype comparisons, vaccine-induced immune responses

Vaccine Details

Vaccine type protein
Vaccine strain B clade
Vaccine component Tat

Notes

Showing 1 of 1 note.

References

Showing 1 of 1 reference.

Richardson2003 Max W Richardson, Jyotika Mirchandani, Joseph Duong, Sammy Grimaldo, Virginia Kocieda, Houria Hendel, Kamel Khalili, Jean-François Zagury, and Jay Rappaport. Antibodies to Tat and Vpr in the GRIV Cohort: Differential Association with Maintenance of Long-Term Non-Progression Status in HIV-1 Infection. Biomed. Pharmacother., 57(1):4-14, Jan 2003. PubMed ID: 12642031. Show all entries for this paper.


Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health